Alphabet-A
GOOGL
Apple
AAPL
Alphabet-C
GOOG
D.R. Horton
DHI
KB Home
KBH
US Stock MarketDetailed Quotes
CARM Carisma Therapeutics
- 0.400
- 0.000-0.07%
Trading Mar 4 10:40 ET
16.70MMarket Cap-0.26P/E (TTM)
0.419High0.390Low87.08KVolume0.400Open0.400Pre Close35.29KTurnover0.29%Turnover RatioLossP/E (Static)41.75MShares2.66052wk High-1.50P/B12.09MFloat Cap0.38052wk Low--Dividend TTM30.22MShs Float51.357Historical High--Div YieldTTM7.32%Amplitude0.380Historical Low0.405Avg Price1Lot Size
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Carisma Therapeutics Stock Forum
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEV...
📊⚡️📊
in progress 😎
Carisma Therapeutics Announces Strategic Restructuring to Re-prioritize Pipeline
Monday, 9th December at 8:30 am
Resources realigned to focus primarily on in vivo macrophage engineering platform for fibrosis, oncology and autoimmune disease therapies
Development of CT-0525 to be discontinued; workforce reduced by 34%
PHILADELPHIA, Dec. 9, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a leader in macrophage-focused ...
No comment yet